Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation.

Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, Rosengard AM, Kotwal GJ, Atkinson JP.

J Immunol. 2006 Mar 15;176(6):3725-34.

2.

Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.

Kreisel D, Krasinskas AM, Krupnick AS, Gelman AE, Balsara KR, Popma SH, Riha M, Rosengard AM, Turka LA, Rosengard BR.

J Immunol. 2004 Sep 1;173(5):3027-34.

3.

Variola virus immune evasion proteins.

Dunlop LR, Oehlberg KA, Reid JJ, Avci D, Rosengard AM.

Microbes Infect. 2003 Sep;5(11):1049-56. Review.

PMID:
12941397
4.

Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Rosengard AM, Liu Y, Nie Z, Jimenez R.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8808-13. Epub 2002 May 28.

5.

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).

Rosengard AM, Alonso LC, Korb LC, Baldwin WM 3rd, Sanfilippo F, Turka LA, Ahearn JM.

Mol Immunol. 1999 Jul;36(10):685-97.

PMID:
10509819
6.

Viral complement regulatory proteins.

Rosengard AM, Ahearn JM.

Immunopharmacology. 1999 May;42(1-3):99-106. Review.

PMID:
10408371
7.

Antibody response to a T-dependent antigen requires B cell expression of complement receptors.

Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC.

J Exp Med. 1996 Apr 1;183(4):1857-64.

8.

Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection.

Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ.

Transplantation. 1995 May 15;59(9):1325-33.

PMID:
7539168
9.

Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.

Rosengard AM, Cary N, Horsley J, Belcher C, Langford G, Cozzi E, Wallwork J, White DJ.

Transplant Proc. 1995 Feb;27(1):326-7. No abstract available.

PMID:
7533400
10.

Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.

Barnes R, Masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA, et al.

Am J Pathol. 1991 Aug;139(2):245-50.

11.

Identification of a second human nm23 gene, nm23-H2.

Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS.

Cancer Res. 1991 Jan 1;51(1):445-9.

12.

Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development.

Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IM, King CR, Liotta LA, Steeg PS.

Nature. 1989 Nov 9;342(6246):177-80.

PMID:
2509941
14.

Squamous carcinoma of the esophagus in patients with Barrett esophagus.

Rosengard AM, Hamilton SR.

Mod Pathol. 1989 Jan;2(1):2-7.

PMID:
2922388

Supplemental Content

Loading ...
Support Center